Axel Dignass

Goethe University Frankfurt

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (10)

Joana Roseira

PORTUGAL

View details

Andreas Stallmach

GERMANY

View details

Taku Kobayashi

Kitasato University

JAPAN

View details

Rupert Leong

Professor of Medicine (Conjoint)

The University of Sydney School of Medicine

AUSTRALIA

View details

Britta Siegmund

GERMANY

View details

Maria Manuela Estevinho

PORTUGAL

View details

Jürgen Stein

Head of Department

Guthrie Clinic Sayre

GERMANY

View details

Alessandro Armuzzi

Humanitas University

ITALY

View details

Mathurin Fumery

FRANCE

View details

Jakob Begun

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Axel Dignass

Research Interests

Explore related searches

Contact this professor

Articles (11)

iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis

Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries

Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease

Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease

Review article: Translating STRIDE‐II into clinical reality – Opportunities and challenges

Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis

International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients

Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis

Letter to the editor: in response to: Richard F Pollock & Patrick Biggar. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia

Cost-effectiveness of tofacitinib compared with infliximab, adalimumab, golimumab, vedolizumab and ustekinumab for the treatment of moderate to severe ulcerative colitis in Germany

Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn’s disease

Collaborators (10)

Joana Roseira

Andreas Stallmach

Taku Kobayashi

Rupert Leong

Britta Siegmund

Maria Manuela Estevinho

Jürgen Stein

Alessandro Armuzzi

Mathurin Fumery

Jakob Begun

Make your next move.